These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20077513)

  • 41. Sample size determination for the non-randomised triangular model for sensitive questions in a survey.
    Tian GL; Tang ML; Zhenqiu Liu ; Ming Tan ; Tang NS
    Stat Methods Med Res; 2011 Jun; 20(3):159-73. PubMed ID: 19221169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brick tunnel randomization for unequal allocation to two or more treatment groups.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2011 Apr; 30(8):812-24. PubMed ID: 21432876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal sample sizes for precise interval estimation of Welch's procedure under various allocation and cost considerations.
    Shieh G; Jan SL
    Behav Res Methods; 2012 Mar; 44(1):202-12. PubMed ID: 21805061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of a guarantee time on sample size determination for testing the ratio of means from two lifetime distributions.
    Xiong C; Miller JP; Yan Y; Ji M
    J Biopharm Stat; 2004 Feb; 14(1):177-88. PubMed ID: 15027507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome.
    Royston P; B Parmar MK
    Trials; 2020 Apr; 21(1):315. PubMed ID: 32252820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and analysis for survival data under order restrictions with a modified logrank test.
    Liu PY; Tsai WY; Wolf M
    Stat Med; 1998 Jul; 17(13):1469-79. PubMed ID: 9695192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sample size planning for survival prediction with focus on high-dimensional data.
    Götte H; Zwiener I
    Stat Med; 2013 Feb; 32(5):787-807. PubMed ID: 22859340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sample size calculation for the augmented logrank test in randomized clinical trials.
    Hattori S; Komukai S; Friede T
    Stat Med; 2022 Jun; 41(14):2627-2644. PubMed ID: 35319100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints.
    Cortés Martínez J; Geskus RB; Kim K; Melis GG
    BMC Med Res Methodol; 2021 May; 21(1):99. PubMed ID: 33957892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A simple method of sample size calculation for unequal-sample-size designs that use the logrank or t-test.
    Hsieh FY
    Stat Med; 1987; 6(5):577-81. PubMed ID: 3659667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sequence balance minimisation: minimising with unequal treatment allocations.
    Madurasinghe VW
    Trials; 2017 May; 18(1):207. PubMed ID: 28468678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sample size and power for a logrank test and Cox proportional hazards model with multiple groups and strata, or a quantitative covariate with multiple strata.
    Lachin JM
    Stat Med; 2013 Nov; 32(25):4413-25. PubMed ID: 23670965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal sample size allocation for Welch's test in one-way heteroscedastic ANOVA.
    Shieh G; Jan SL
    Behav Res Methods; 2015 Jun; 47(2):374-83. PubMed ID: 24903689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maximum information designs.
    Lachin JM
    Clin Trials; 2005; 2(5):453-64. PubMed ID: 16315649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An asymptotic analysis of the logrank test.
    Strawderman RL
    Lifetime Data Anal; 1997; 3(3):225-49. PubMed ID: 9384654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized two-stage optimal design for interval-censored data.
    Shan G
    J Biopharm Stat; 2022 Mar; 32(2):298-307. PubMed ID: 34890525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Applicability of sample size calculations based on a comparison of proportions for use with the logrank test.
    Gail MH
    Control Clin Trials; 1985 Jun; 6(2):112-9. PubMed ID: 4006484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factorial designs: a graphical aid for choosing study designs accounting for interaction.
    Byth K; Gebski V
    Clin Trials; 2004; 1(3):315-25. PubMed ID: 16279257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and analysis of multiarm clinical trials with survival endpoints.
    Liu PY; Dahlberg S
    Control Clin Trials; 1995 Apr; 16(2):119-30. PubMed ID: 7789135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The net effect of alternative allocation ratios on recruitment time and trial cost.
    Vozdolska R; Sano M; Aisen P; Edland SD
    Clin Trials; 2009 Apr; 6(2):126-32. PubMed ID: 19342464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.